vs
Side-by-side financial comparison of MACROGENICS INC (MGNX) and PCB BANCORP (PCB). Click either name above to swap in a different company.
MACROGENICS INC is the larger business by last-quarter revenue ($41.2M vs $29.2M, roughly 1.4× PCB BANCORP). On growth, MACROGENICS INC posted the faster year-over-year revenue change (113.0% vs 11.3%). MACROGENICS INC produced more free cash flow last quarter ($42.8M vs $24.4M). Over the past eight quarters, MACROGENICS INC's revenue compounded faster (112.8% CAGR vs 10.4%).
MacroGenics Inc is a clinical-stage biopharmaceutical firm specializing in the research and development of novel immunotherapies for cancer and autoimmune disorders. Its core product pipeline centers on monoclonal antibody-based treatments, with key programs targeting solid tumors and hematological malignancies, supported by partnerships with global pharmaceutical partners.
PCB Bank is an American community bank that focuses on the Korean-American community based in California and offers commercial banking services. It has branches in 8 states and is the third largest Korean American Bank after Bank of Hope and Hanmi Bank.
MGNX vs PCB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $41.2M | $29.2M |
| Net Profit | — | — |
| Gross Margin | — | — |
| Operating Margin | -29.3% | 45.0% |
| Net Margin | — | — |
| Revenue YoY | 113.0% | 11.3% |
| Net Profit YoY | — | — |
| EPS (diluted) | $-0.23 | $0.65 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $41.2M | $29.2M | ||
| Q3 25 | $72.8M | $30.4M | ||
| Q2 25 | $22.2M | $29.3M | ||
| Q1 25 | $13.2M | $26.9M | ||
| Q4 24 | $19.4M | $26.2M | ||
| Q3 24 | $110.7M | $25.3M | ||
| Q2 24 | $10.8M | $24.2M | ||
| Q1 24 | $9.1M | $23.9M |
| Q4 25 | — | — | ||
| Q3 25 | $16.8M | $11.4M | ||
| Q2 25 | $-36.3M | $9.1M | ||
| Q1 25 | $-41.0M | $7.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | $56.3M | $7.8M | ||
| Q2 24 | $-55.7M | $6.3M | ||
| Q1 24 | $-52.2M | $4.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 98.8% | — | ||
| Q3 24 | 99.8% | — | ||
| Q2 24 | 98.4% | — | ||
| Q1 24 | 97.0% | — |
| Q4 25 | -29.3% | 45.0% | ||
| Q3 25 | 25.6% | 52.3% | ||
| Q2 25 | -165.3% | 43.3% | ||
| Q1 25 | -323.1% | 40.2% | ||
| Q4 24 | -273.0% | 39.3% | ||
| Q3 24 | 48.9% | 42.2% | ||
| Q2 24 | -538.9% | 36.3% | ||
| Q1 24 | -590.4% | 27.2% |
| Q4 25 | — | — | ||
| Q3 25 | 23.1% | 37.5% | ||
| Q2 25 | -163.0% | 31.0% | ||
| Q1 25 | -311.1% | 28.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | 50.9% | 30.8% | ||
| Q2 24 | -515.6% | 25.9% | ||
| Q1 24 | -573.3% | 19.6% |
| Q4 25 | $-0.23 | $0.65 | ||
| Q3 25 | $0.27 | $0.78 | ||
| Q2 25 | $-0.57 | $0.62 | ||
| Q1 25 | $-0.65 | $0.53 | ||
| Q4 24 | $-0.24 | $0.46 | ||
| Q3 24 | $0.90 | $0.52 | ||
| Q2 24 | $-0.89 | $0.43 | ||
| Q1 24 | $-0.84 | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $57.2M | $207.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $55.6M | $390.0M |
| Total Assets | $256.8M | $3.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $57.2M | $207.1M | ||
| Q3 25 | $80.1M | $369.5M | ||
| Q2 25 | $130.7M | $263.6M | ||
| Q1 25 | $145.6M | $214.3M | ||
| Q4 24 | $182.8M | $198.8M | ||
| Q3 24 | $179.6M | $193.1M | ||
| Q2 24 | $83.9M | $177.6M | ||
| Q1 24 | $80.4M | $239.8M |
| Q4 25 | $55.6M | $390.0M | ||
| Q3 25 | $67.0M | $384.5M | ||
| Q2 25 | $46.6M | $376.5M | ||
| Q1 25 | $79.1M | $370.9M | ||
| Q4 24 | $116.1M | $363.8M | ||
| Q3 24 | $120.1M | $362.3M | ||
| Q2 24 | $57.8M | $353.5M | ||
| Q1 24 | $106.2M | $350.0M |
| Q4 25 | $256.8M | $3.3B | ||
| Q3 25 | $270.8M | $3.4B | ||
| Q2 25 | $245.4M | $3.3B | ||
| Q1 25 | $224.6M | $3.2B | ||
| Q4 24 | $261.7M | $3.1B | ||
| Q3 24 | $264.5M | $2.9B | ||
| Q2 24 | $201.1M | $2.9B | ||
| Q1 24 | $248.3M | $2.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $43.0M | $26.6M |
| Free Cash FlowOCF − Capex | $42.8M | $24.4M |
| FCF MarginFCF / Revenue | 103.8% | 83.6% |
| Capex IntensityCapex / Revenue | 0.6% | 7.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-83.0M | $46.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $43.0M | $26.6M | ||
| Q3 25 | $-30.2M | $16.4M | ||
| Q2 25 | $-47.0M | $4.9M | ||
| Q1 25 | $-46.9M | $2.3M | ||
| Q4 24 | $-38.4M | $39.0M | ||
| Q3 24 | $60.2M | $11.9M | ||
| Q2 24 | $-44.5M | $14.6M | ||
| Q1 24 | $-45.6M | $8.2M |
| Q4 25 | $42.8M | $24.4M | ||
| Q3 25 | $-30.6M | $16.2M | ||
| Q2 25 | $-47.7M | $3.8M | ||
| Q1 25 | $-47.4M | $1.6M | ||
| Q4 24 | $-39.0M | $34.9M | ||
| Q3 24 | $59.6M | $11.9M | ||
| Q2 24 | $-45.5M | $12.8M | ||
| Q1 24 | $-47.1M | $6.0M |
| Q4 25 | 103.8% | 83.6% | ||
| Q3 25 | -42.0% | 53.2% | ||
| Q2 25 | -214.5% | 13.1% | ||
| Q1 25 | -359.5% | 6.0% | ||
| Q4 24 | -201.7% | 133.2% | ||
| Q3 24 | 53.8% | 46.8% | ||
| Q2 24 | -421.6% | 53.1% | ||
| Q1 24 | -517.4% | 25.2% |
| Q4 25 | 0.6% | 7.5% | ||
| Q3 25 | 0.6% | 0.8% | ||
| Q2 25 | 3.2% | 3.7% | ||
| Q1 25 | 4.0% | 2.8% | ||
| Q4 24 | 3.2% | 15.5% | ||
| Q3 24 | 0.5% | 0.1% | ||
| Q2 24 | 9.6% | 7.3% | ||
| Q1 24 | 16.0% | 9.3% |
| Q4 25 | — | — | ||
| Q3 25 | -1.79× | 1.44× | ||
| Q2 25 | — | 0.54× | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.07× | 1.52× | ||
| Q2 24 | — | 2.33× | ||
| Q1 24 | — | 1.76× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MGNX
| Revenue From Collaborative Agreements | $20.3M | 49% |
| Contract Manufacturing | $11.3M | 27% |
| Other | $9.7M | 23% |
PCB
Segment breakdown not available.
